|1.||Rosendaal, F R: 21 articles (10/2015 - 04/2000)|
|2.||Bertina, R M: 10 articles (03/2008 - 04/2000)|
|3.||Rosendaal, Frits R: 9 articles (08/2012 - 01/2002)|
|4.||Vos, H L: 7 articles (10/2012 - 04/2000)|
|5.||van Hylckama Vlieg, A: 6 articles (09/2012 - 06/2000)|
|6.||Cannegieter, S C: 3 articles (10/2015 - 03/2010)|
|7.||de Visser, M C H: 3 articles (05/2011 - 08/2004)|
|8.||Bertina, Rogier M: 3 articles (06/2007 - 10/2002)|
|9.||Lijfering, W M: 2 articles (10/2015 - 09/2012)|
|10.||Callas, P W: 2 articles (04/2013 - 03/2003)|
02/01/2014 - "In this framework, the genetic instability of tumor cells represents a local-scale driving force for instability that lets the tumor evolve with time, while selective pressures discarding inefficient cell clones play the role of a dissipative process, providing the tumor with global stability and robustness with respect to perturbations. "
05/01/2012 - "The concept of having an 'intrinsic subtype,' or a molecular taxonomy, lets us clearly recognize that breast cancers have characteristically different patterns of gene expression, thus giving newfound significance to morphological taxonomy. "
01/01/2012 - "Teenage Cancer Trust education & advocacy program: 'lets talk about it' a United Kingdom approach."
12/19/2011 - "A gene test lets some patients with early tumors skip radiation."
08/01/2011 - "This approach increases sensitivity, but also lets the numbers of 'insignificant cancers' rise. "
|2.||Substance-Related Disorders (Drug Abuse)
06/01/2011 - "The current study tested the efficacy of LETS ACT compared to a contact-time matched control condition, supportive counseling (SC), examining effects on depressed mood, substance abuse treatment retention, and behavioral activation outcomes. "
06/01/2011 - "This study was the first to compare LETS ACT to a contact-time matched control treatment to evaluate effects on substance abuse treatment retention and two distinct measures of behavioral activation: overall activation and environmental reward. "
06/01/2011 - "Fifty-eight adult substance users in residential substance abuse treatment presenting with depressive symptoms (BDI≥12) were randomly assigned to LETS ACT or SC. "
06/01/2011 - "The Life Enhancement Treatment for Substance Use (LETS ACT; Daughters et al., 2008) is a behavioral activation-based approach tailored to increase levels of positive reinforcement among depressed substance users while in substance abuse treatment. "
06/01/2011 - "Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention."
04/01/2013 - "Findings were replicated in the Leiden Thrombophilia Study (LETS). "
08/01/2012 - "The objective of this study was to correlate a novel, systems-based metric of clotting potential to risk of DVT from a database derived from the Leiden Thrombophilia Study (LETS). "
06/01/2012 - "An association between elevated plasma FVIII levels and VTE was first described in the Leiden Thrombophilia Study (LETS). "
05/01/2011 - "Four haplotypes of PROCR, two SNPs in the neighboring gene EDEM2 and critical SNPs encountered during resequencing were genotyped in the family and in a large group of healthy individuals (the Leiden Thrombophilia Study (LETS) controls). "
05/01/2008 - "Data from patients enrolled in the Leiden Thrombophilia Study (LETS) (n = 443) and the first Cambridge Prospective Cohort Study (n = 374) were combined. "
|5.||Venous Thrombosis (Deep-Vein Thrombosis)
10/01/2015 - "In four pooled European cohorts (CARROT study, Glasgow, UK; CVTE study, Cambridge, UK; AUREC study, Vienna, Austria; and LETS follow-up study, Leiden, the Netherlands), the risk of recurrent venous thrombosis was calculated in men, women with reproductive risk factors and women without reproductive risk factors at the time of their first venous thrombosis. "
03/01/2010 - "Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study."
10/01/2012 - "Second, because multiple regulatory factors affect SHBG levels and residual confounding may remain, we determined six single-nucleotide polymorphisms (SNPs) in the SHBG gene and assessed the risk of venous thrombosis in a different case-control study, the Leiden Thrombophilia Study (LETS) (20 patients; 74 controls), and in the MEGA study. "
11/01/2009 - "The study populations were the Leiden Thrombophilia Study (LETS) (443 DVT cases and 453 controls) and the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA study) (2712 DVT cases and 4634 controls). "
06/01/2007 - "In a case-control study on the causes of deep venous thrombosis, the Leiden Thrombophilia Study (LETS), we genotyped 18 single nucleotide polymorphisms (SNPs) in IL1B, IL1RN, IL1R1, and IL1R2, enabling us to tag a total of 25 haplotype groups. "
|1.||benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)
|4.||Factor V (Coagulation Factor V)
|9.||Interleukin-8 (Interleukin 8)
|10.||Prothrombin (Factor II)
|2.||Drug Therapy (Chemotherapy)
|3.||Prostheses and Implants (Prosthesis)
|5.||Intermittent Urethral Catheterization